WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelled
DDA seizes suspected counterfeit asthma medicine in nationwide crackdown
HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses
Eli Lilly launches cancer drug Tanstrive in India
Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals
Centre eases BIS quality compliance with new risk-based framework for manufacturers
SS Innovations International aces Race beating Global Giants in Surgical Robotics
‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility
India curbs supply of IVF consumables to unregistered clinics
Maha FDA seizes counterfeit skincare products; FIR registered
Rajasthan Bans 7 Sub-Standard Medicines
Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality”. Prioritising…
ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection
OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…
Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…
Obesity drug market to gain as Indians pop the pill and Chinese bring more
Mumbai: A flood of oral GLP1 weight-loss pills, including from China, may redraw India’s obesity treatment market by this year-end, said industry executives and top endocrinologists. Nearly a dozen oral…
Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23
New Delhi: Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…
Boehringer Ingelheim launches AI centre for pharma research in London
Bengaluru: German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning in London, it said on Monday, as it seeks to expand its AI capabilities in…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…
Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates
New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…
Piramal, Ajinomoto team on ADC development and manufacturing
Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…
Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid
New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…
